CME vs CTAS · P/E 22, rev $3.59B vs P/E 51, rev $11.26B
CME Group Inc (CME) versus Cintas Corporation (CTAS) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
CME currently screens at market cap $91.25B and trailing P/E 21.9. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Not investment advice. Open the CME and CTAS stock pages for the full models.
Not investment advice.